3.87
-0.03(-0.77%)
Currency In USD
| Previous Close | 3.9 |
| Open | 3.98 |
| Day High | 4 |
| Day Low | 3.84 |
| 52-Week High | 24.42 |
| 52-Week Low | 1.35 |
| Volume | 338,461 |
| Average Volume | 1.03M |
| Market Cap | 44.15M |
| PE | -0.43 |
| EPS | -8.92 |
| Moving Average 50 Days | 3.81 |
| Moving Average 200 Days | 3.51 |
| Change | -0.03 |
If you invested $1000 in X4 Pharmaceuticals, Inc. (XFOR) since IPO date, it would be worth $1.53 as of January 14, 2026 at a share price of $3.87. Whereas If you bought $1000 worth of X4 Pharmaceuticals, Inc. (XFOR) shares 5 years ago, it would be worth $15.83 as of January 14, 2026 at a share price of $3.87.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
X4 Pharmaceuticals to Participate in Guggenheim’s Second Annual Healthcare Innovation Conference
GlobeNewswire Inc.
Nov 05, 2025 9:01 PM GMT
BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare hematology diseases, today announced that the management team will participate in the upcoming Guggenheim Second
X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million
GlobeNewswire Inc.
Oct 27, 2025 11:05 PM GMT
BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR) (“X4” or the “Company”), a company driven to improve the lives of people with rare hematology diseases, today announced the closing of its previously announced underwritten
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering
GlobeNewswire Inc.
Oct 24, 2025 4:37 AM GMT
BOSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR) (“X4” or the “Company”), a company driven to improve the lives of people with rare hematology diseases, today announced the pricing of its previously announced underwritten